Sponsor or institution
Clinical trials and research at Neovaxsyn, INC.
As of November 12, 2026, Find a Trial lists 4 NIH-funded research projects at this institution, with $2.9 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4NIH research projects
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
A new, better way to make rAAV gene therapy vectors
Aims to create a better, higher-quality rAAV production method to support future gene therapies and vaccines.
-
Developing a new type of vaccine to generate broad antibodies against HIV-1
This study is testing a new type of vaccine that uses tiny particles to help your body fight HIV better, aiming to boost your immune system to produce strong antibodies that can protect you from the virus.
-
Creating new ways to prevent HIV-1 infection using advanced antibodies
This study is working on new ways to deliver special antibodies that can help prevent HIV-1 infection, especially for women, by making them stronger and longer-lasting, so they can better protect against different types of the virus.
-
Creating a vaccine to generate antibodies against HIV-1.
This study is testing a new type of vaccine designed to help your body make powerful antibodies that can fight off many strains of HIV-1, with the hope of reducing infections and making a big difference in the battle against AIDS.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.